<--- Back to Details
First PageDocument Content
Organofluorides / Protease inhibitors / Integrase inhibitors / Amides / Xenotropic murine leukemia virus-related virus / Reverse-transcriptase inhibitor / Antiretroviral drug / Raltegravir / Zidovudine / Chemistry / Organic chemistry / HIV/AIDS
Organofluorides
Protease inhibitors
Integrase inhibitors
Amides
Xenotropic murine leukemia virus-related virus
Reverse-transcriptase inhibitor
Antiretroviral drug
Raltegravir
Zidovudine
Chemistry
Organic chemistry
HIV/AIDS

Smith et al. Retrovirology 2010, 7:70 http://www.retrovirology.com/content[removed]

Add to Reading List

Source URL: www.retrovirology.com

Download Document from Source Website

File Size: 1,11 MB

Share Document on Facebook

Similar Documents

DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE

DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE

DocID: 1pw8Q - View Document

Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). Ada

Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). Ada

DocID: 1pbRe - View Document

New Zealand Consumer Medicine Information  Viramune Tablets and Oral Suspension Nevirapine

New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine

DocID: 1gvCL - View Document

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

DocID: 1gtrY - View Document

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

DocID: 1fNy0 - View Document